The occurrence of pulmonary aspergillosis and of precipitins, positive skin tests, and sputum containing abundant Aspergillus fumigatus has been assessed and correlated in a survey of 107 consecutive patients attending hospital in Bristol with various chronic chest diseases. The series included three with aspergilloma, five with allergic aspergillosis, and one with chronic invasive aspergillosis. Of 46 asthmatic patients, 11 % had definite and 22 % had probable or definite allergic aspergillosis.
Pulmonary aspergillosis, in its various forms, is most commonly caused by the species Aspergillus fumigatus, the spores of which are widely disseminated in the atmosphere. The fungus colonizes diseased air spaces (Okudaira and Schwarz, 1962) and sometimes grows to form obvious aspergillomas (Deve, 1938) . It can become invasive, usually when host defences are impaired (Finegold, Will, and Murray, 1959; Symmers, 1964) , although occasional instances of systemic infection in previously healthy individuals have been reported (Strelling, Rhaney, Simmons, and Thomson, 1966) . It may also cause allergic reactions, resulting in episodic airways obstruction, pulmonary shadows, and eosinophilia (Hinson, Moon, and Plummer, 1952; Pepys, Riddel, Citron, Clayton, and Short, 1959) .
Culture of A. fumigatus from the sputum may indicate only coincidental contamination (Camp-' Clayton, 1964) . Conversely, sputum cultures from patients with pulmonary aspergillosis have often not yielded the fungus (Belcher and Plummer, 1960) . Serum precipitins and skin tests are of diagnostic value in cases of aspergilloma and allergic aspergillosis but are found also in other patients with lung disease (Pepys et al., 1959; Campbell and Clayton, 1964; Longbottom and Pepys, 1964) . This paper reports the results of a survey of patients with chronic lung disease, studied for evidence of aspergillosis. The significance of positive tests is discussed, with particular reference to those patients who cannot with certainty be shown to have aspergilloma or allergic aspergillosis. chronic lung disease who were seen routinely over the course of one year from April 1965 by one of us (A. H. H.) .
The discussion on the significance' of laboratory findings is based on these 107, together with 21 addi-' tional patients with aspergillosis seen by A. H. H. (including the 17 described in this issue (Henderson, 1968) as well as three patients from whom aspergillomas had been resected and one patient with acute disseminated aspergillosis).
DEFINITIONS AND METHODS
Methods have been described and. definitions of the types of aspergillosis given in previous papers (English and Henderson, 1968; Henderson, 1968 Table I shows the clinical and laboratory features of patients with aspergillosis and also of all patients with asthma. Table II shows the features of patients without definite aspergillosis.
There were three patients with aspergilloma, five with allergic aspergillosis, and one with invasive aspergillosis-a total of nine with definite pulmonary aspergillosis. Five (11 %) of the 46 patients with asthma had allergic aspergillosis.
Some degree of chronic upper lobe contraction was radiographically evident in seven (15%) of the asthmatic patients, two of whom had established long-standing allergic aspergillosis, and the other five of whom all had probable long-standing allergic aspergillosis (Henderson, 1968 sputum were similar in those on steroid therapy and those not on steroid therapy.
LABORATORY AND CLINICAL FEATURES
Patients with aspergillosis The findings in patients with aspergillosis are summarized in Tables I and III . Two patients were shown at necropsy to have invasive aspergillosis. One of these had probably also had long-standing allergic aspergillosis: histological examination of the lungs showed hyphae penetrating the bronchial walls and within giant cell granulomata. The other patient died from acute pneumonic and disseminated aspergillosis after two months of high dosage steroid and azathioprine therapy for pemphigus. The fungus was recovered from the sputum in both cases: it had been present for at least a year in the first case and in each was found in large quantities at necropsy. Tables III  and IV show that in survey patients without definite aspergillosis, precipitins and positive sputum were significantly associated. The coincident development of positive sputum and of increasingly strong precipitins is illustrated in the Figure. Ten survey patients had precipitins. The five with asthma all had positive skin tests, and the five without asthma had negative skin tests. Of one, became positive after the period of the survey in another, and was not examined in a third patient. Of the patients without asthma, one (precipitins strength A) had cavitated sarcoid with positive sputum, and three (precipitins strengths C, D, and D) had bronchiectasis, two with positive sputum; the fifth patient (precipitins strength D) had chronic bronchitis, but no fungus was found in the only specimen of sputum available.
Patients without definite aspergillosis
Of the two patients with positive sputum but no precipitins, one had chronic bronchitis with recent asthma, and sputum repeatedly contained A. fumigatus hyphae for three weeks but not thereafter. The other (Figure, c) was a young woman with asthma, eosinophilia, and persistently positive sputum for nine months, during which period the skin test became positive on retesting. Precipitins have not been demonstrated in either of these last two patients despite follow-up for a year and the use of concentrated serum.
The development of increasingly strong precipitins was observed in three patients. In two (Figure, a, b ) this was coincident with recovery of the fungus from sputum, previous specimens of which had been negative. One patient outside the survey, who had had pulmonary eosinophilia in the past before her asthma was controlled with steroids, had a positive skin test and weak precipitins but no evidence of current fungal infection at necropsy. DISCUSSION INCIDENCE OF PULMONARY ASPERGILLOSIS The incidence of the different types of pulmonary aspergillosis is not known, although necropsy reviews have shown an increasing number of cases of invasive aspergillosis (Heffernan and Asper, 1966) . Pepys et al. (1959) found that patients with aspergilloma comprised 02% of 2,080 patients whose sputum was examined, and Macpherson (1965) found aspergilloma in 0-01% of a population of 60,000 from a review of radiographs taken in the preceding 10 years. The diagnosis of allergic aspergillosis in our survey has been confined to patients fulfilling all the given diagnostic criteria (airways obstruction, pulmonary eosinophilia, positive skin test, and positive sputum), thereby excluding some patients with potential allergy or only limited allergic reactions while under observation. Our finding of allergic aspergillosis in 5 out of 46 patients with asthma (11%) attending hospital is similar to the estimated 8% derived from a combined analysis of two published series (Pepys et al., 1959; Campbell and Clayton, 1964 Patients with sputum cultures yielding abundant fungus were found as often in the Bristol series as were total positive cultures in other reported series, possibly reflecting the fact that all specimens were examined by a mycologist. In all patients with allergic aspergillosis the fungus was isolated on examination of no more than three random specimens, none of which contained obvious plugs. The proportions of precipitins in patients with lung disease other than definite aspergillosis are similar to those found by other workers (Longbottom and Pepys, 1964; Mearns, Longbottom, and Batten, 1967) . Positive skin tests were found less often in our series than in other published series. This may be related to our use of the intradermal instead of the prick method of testing and to our acceptance only of strongly positive results.
Positive sputum cultures and precipitins were found most commonly in patients with asthma, bronchiectasis, or cavitated lungs.
UPPER LOBE CONTRACTION
Some degree of chronic contraction of the upper lobes not attributable to other known disease was found in seven (15%) of the asthmatic patients in the survey: all showed evidence of chronic fungal infection and hypersensitivity and probably had long-standing allergic aspergillosis. If these patients are included, the proportion of survey patients with asthma who had allergic aspergillosis becomes 22%. PRECIPITINS The precise significance of precipitins in the diagnosis and pathogenesis of the different types of aspergillosis is not yet fully understood.
Precipitins are strongly present in almost all cases of aspergilloma (Table V) and slowly disappear after resection of the aspergilloma in some cases (Longbottom and Pepys, 1964) (Table III) . They occur in almost 10% of non-asthmatic patients with chronic lung disease (Table V) , being found most commonly in patients with severely diseased lungs (Bronnestam and Hallberg, 1965; Mearns et al., 1967) e. Macpherson (1965) Series of 6 cases of aspergilloma out of 56 patients with cavitated lung, found after review of radiographs 1954 -1963 giving pre- cipitin results. f. Mearns, Longbottom, and Batten (1967) Series of 60 patients with asthma, giving precipitin results.
g. Pepys (1966) (Longbottom and Pepys, 1964; Campbell and Clayton, 1964) and are said to be present in almost all cases, if the test is carried out with concentrated serum (Pepys, 1966) . They were present in all our cases, and there is some evidence that their strength was related to the amount and duration of fungal growth (Henderson, 1968 
